TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+0.51%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.57B
AUM Growth
+$2.57B
(-0.83%)
Cap. Flow
+$49.2M
Cap. Flow
% of AUM
1.91%
Top 10 Holdings %
Top 10 Hldgs %
39.02%
Holding
198
New
37
Increased
49
Reduced
41
Closed
10
Top Buys
| 1 |
Pfizer
PFE
|
$38.2M |
| 2 |
Johnson & Johnson
JNJ
|
$20.1M |
| 3 |
Esperion Therapeutics
ESPR
|
$13.7M |
| 4 |
Nektar Therapeutics
NKTR
|
$13.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
$11.2M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$34.4M |
| 2 |
Amgen
AMGN
|
$27.5M |
| 3 |
Biogen
BIIB
|
$18.3M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$17.9M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$16.9M |
Sector Composition
| 1 | Healthcare | 93.47% |
| 2 | Real Estate | 2.71% |
| 3 | Financials | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Medical Properties Trust
MPW
$2.66B
| $11.2M | 0.43% |
858,586
| – | – |
|
|
WELL.PRI
52
DELISTED
Welltower Inc.
WELL.PRI
| $11.1M | 0.43% |
200,000
| – | – |
|
|
XLRN
53
DELISTED
Acceleron Pharma Inc.
XLRN
| $10.7M | 0.42% |
273,098
-10,285
| -4% | -$402K |
|
54
Acadia Healthcare
ACHC
$2.15B
| $10.7M | 0.42% |
272,400
| – | – |
|
55
Stryker
SYK
$149B
| $10.3M | 0.4% |
64,258
+32,758
| +104% | +$5.27M |
|
|
DHC
56
Diversified Healthcare Trust
DHC
$903M
| $10.1M | 0.39% |
646,554
| – | – |
|
|
ADAP
57
Adaptimmune Therapeutics
ADAP
$13.9M
| $9.61M | 0.37% |
855,468
-79,900
| -9% | -$897K |
|
58
Galapagos
GLPG
$2.06B
| $9.54M | 0.37% |
95,635
+42,435
| +80% | +$4.23M |
|
59
Cigna
CI
$80.2B
| $9.49M | 0.37% |
56,563
-43,439
| -43% | -$7.29M |
|
60
Edwards Lifesciences
EW
$47.7B
| $9.25M | 0.36% |
66,275
+1,175
| +2% | +$164K |
|
|
MDCO
61
DELISTED
Medicines Co
MDCO
| $9.17M | 0.36% |
+278,391
| New | +$9.17M |
|
62
Zimmer Biomet
ZBH
$20.8B
| $8.95M | 0.35% |
82,080
+1,780
| +2% | +$194K |
|
|
CLLS
63
Cellectis
CLLS
$260M
| $8.93M | 0.35% |
283,250
-27,000
| -9% | -$851K |
|
64
HCA Healthcare
HCA
$95.4B
| $8.91M | 0.35% |
91,881
+28,449
| +45% | +$2.76M |
|
65
Merus
MRUS
$5.04B
| $8.88M | 0.35% |
479,150
| – | – |
|
|
DPLO
66
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $8.85M | 0.34% |
439,001
-201,491
| -31% | -$4.06M |
|
|
AVXS
67
DELISTED
AveXis, Inc. Common Stock
AVXS
| $8.69M | 0.34% |
70,347
| – | – |
|
|
EPZM
68
DELISTED
Epizyme, Inc
EPZM
| $8.62M | 0.34% |
485,325
+29,325
| +6% | +$521K |
|
69
Exelixis
EXEL
$9.95B
| $8.61M | 0.33% |
388,822
| – | – |
|
|
ONC
70
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $8.32M | 0.32% |
49,496
+23,326
| +89% | +$3.92M |
|
|
AET
71
DELISTED
Aetna Inc
AET
| $8.04M | 0.31% |
47,566
| – | – |
|
72
Cencora
COR
$57.2B
| $7.99M | 0.31% |
92,707
-74,600
| -45% | -$6.43M |
|
|
LTC
73
LTC Properties
LTC
$1.67B
| $7.97M | 0.31% |
209,673
| – | – |
|
74
Ultragenyx Pharmaceutical
RARE
$3.04B
| $7.58M | 0.29% |
148,558
| – | – |
|
75
CytomX Therapeutics
CTMX
$350M
| $7.54M | 0.29% |
265,045
| – | – |
|